Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study

6-27-2022: Beijing, China: Control Group=13.93 days, Yindan Jiedu 10-Herbal Group=11.49 days, Paxlovid Group=10.21 days. Paxlovid kills people in the future with inflation, recession, and budget cuts caused by interest payments on the national debt: htt